Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
Trial Information
An In Depth Cardiovascular Study of Lisdexamfetamine (LDX; Vyvanse) in Healthy and Treated Hypertensive Adults with Attention Deficit Hyperactivity Disorder (ADHD)
Adults between the ages of 18-60 having trouble with inattention, concentration, disorganization, restlessness and/or other ADHD symptoms are invited to participate in a research study that examines the effects of a medication of Vyvanse on the heart. This study is a 7-month open-label (involves active medication only, no chance of placebo) trial of Vyvanse. Vyvanse is FDA approved for the treatment of ADHD in adults. Participants will complete an exercise test and heart ultrasound at the beginning and end of the study. Participants will also be given a blood pressure monitor to measure their blood pressure at home during the study. All participants can receive two months of follow-up care at no cost after the completion of the study. Please call 617-724-ADHD for more information.
Mary Schillinger
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-724-ADHD
EMail: pppcresearch@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
